Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public









Cancel


6 Items
Title  Creator  Group name  Publishing year 
TRIM28-dependent SUMOylation protects the adult ovary from activation of the testicular pathway Rossitto et al. EquipeEJ 12/2022
Endogenous Retroviral Sequences Behave as Putative Enhancers Controlling Gene Expression through HP1-Regulated Long-Range Chromatin Interactions Calvet et al. EquipeVC 2022-08-03
HP1s modulate the S-Adenosyl Methionine synthesis pathway in liver cancer cells Mancini et al. PlateformePP2I Mar 13, 2020
Critical role for TRIM28 and HP1?/? in the epigenetic control of T cell metabolic reprograming and effector differentiation Gehrmann et al. EQUIPEFC Dec 17, 2019
In mammalian foetal testes, SOX9 regulates expression of its target genes by binding to genomic regions with conserved signatures Rahmoun et al. EQUIPEFC Jul 07, 2017
TRIM28 represses transcription of endogenous retroviruses in neural progenitor cells Fasching et al. EQUIPEFC Jan 06, 2015
6 Items


Who are we ?

Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).

U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)

More                                                                                                                 Join us

Contact us

Institut de Recherche en Cancérologie de
Montpellier (U1194) - Campus Val d'Aurelle

208 avenue des Apothicaires
34298 Montpellier cedex 5 FRANCE

 

insermUM1ICM

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés